Literature DB >> 10447766

Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora.

H Wang1, X Tan, H Chang, W Huang, F Gonzalez-Crussi, W Hsueh.   

Abstract

Platelet-activating factor (PAF) is a potent mediator involved in bowel injury. We investigated PAF receptor transcription and its mRNA localization in the small intestine of normal (conventionally fed) and germ-free rats, by competitive polymerase chain reaction (PCR) and in situ hybridization. A dose of PAF (1.5 microg/kg, i.v.) insufficient to cause gross bowel injury was injected into rats. Some rats were pretreated with dexamethasone (1 mg/kg). We found: (1) PAF receptor (PAF-R) mRNA localized predominantly in lamina propria eosinophils and in epithelial cells; (2) PAF increased PAF-receptor signals in the epithelial cells; (3) Dexamethasone depleted eosinophils in the intestine and markedly decreased PAF-receptor transcripts; the response to PAF was also weaker than control rats; (4) Germ-free rats had less PAF-R mRNA than normal rats, and showed a weaker response to PAF than conventionally fed rats. Thus, we conclude: (1) PAF receptor mRNA is constitutively expressed in the epithelium and in lamina propria eosinophils in the intestine. (2) PAF-R transcription is up-regulated by PAF and gut flora, mostly in the epithelium. (3) PAF-R transcription is down-regulated by glucocorticoids, mainly as a result of eosinophil depletion. These results suggest a functional role for PAF receptors both in host defence and the inflammatory response in the small intestine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447766      PMCID: PMC2326856          DOI: 10.1046/j.1365-2567.1999.00784.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Paf-acether, an ether phospho-lipid with biological activity.

Authors:  J Benveniste
Journal:  Prog Clin Biol Res       Date:  1988

3.  Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.

Authors:  J L Wallace; B J Whittle
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

4.  Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.

Authors:  R Eliakim; F Karmeli; E Razin; D Rachmilewitz
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

5.  Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.

Authors:  F Bussolino; G Camussi; M Aglietta; P Braquet; A Bosia; G Pescarmona; F Sanavio; N D'Urso; P C Marchisio
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes.

Authors:  A Tailor; A M Das; S J Getting; R J Flower; M Perretti
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

7.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

Authors:  F Gonzalez-Crussi; W Hsueh
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

8.  Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.

Authors:  W Hsueh; F González-Crussi; J L Arroyave
Journal:  FASEB J       Date:  1987-11       Impact factor: 5.191

9.  Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.

Authors:  A G Stewart; G J Dusting
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).

Authors:  C E Sigal; F H Valone; M J Holtzman; E J Goetzl
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

View more
  7 in total

Review 1.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

2.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

Review 3.  Inflammatory signaling in necrotizing enterocolitis.

Authors:  Isabelle G De Plaen
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

4.  Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin.

Authors:  X D Tan; H Chang; X W Qu; M Caplan; F Gonzalez-Crussi; W Hsueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Identification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS Analysis.

Authors:  Vadanasundari Vedarethinam; Karthik Dhanaraj; Ilavenil Soundherrajan; Ravikumar Sivanesan
Journal:  Indian J Clin Biochem       Date:  2015-05-26

Review 6.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

7.  Infection, eosinophilia and childhood asthma.

Authors:  Chang-Keun Kim; Zak Callaway; Takao Fujisawa
Journal:  Asia Pac Allergy       Date:  2012-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.